Titre : Études rétrospectives

Études rétrospectives : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Études rétrospectives : Questions médicales les plus fréquentes", "headline": "Études rétrospectives : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Études rétrospectives : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2026-01-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Études rétrospectives" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Études de cohortes", "url": "https://questionsmedicales.fr/mesh/D015331", "about": { "@type": "MedicalCondition", "name": "Études de cohortes", "code": { "@type": "MedicalCode", "code": "D015331", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750" } } }, "about": { "@type": "MedicalCondition", "name": "Études rétrospectives", "alternateName": "Retrospective Studies", "code": { "@type": "MedicalCode", "code": "D012189", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sanjay Prakash", "url": "https://questionsmedicales.fr/author/Sanjay%20Prakash", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Smt. B. K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara Gujarat, India." } }, { "@type": "Person", "name": "Luis Enrique Jerez Puebla", "url": "https://questionsmedicales.fr/author/Luis%20Enrique%20Jerez%20Puebla", "affiliation": { "@type": "Organization", "name": "Departamento de Parasitología, Instituto \"Pedro Kourí\", Autopista Novia del Mediodía Km 6½ e/Autopista Nacional y Carretera Central, La Habana, Cuba." } }, { "@type": "Person", "name": "Fidel A Núñez Fernández", "url": "https://questionsmedicales.fr/author/Fidel%20A%20N%C3%BA%C3%B1ez%20Fern%C3%A1ndez", "affiliation": { "@type": "Organization", "name": "Departamento de Parasitología, Instituto \"Pedro Kourí\", Autopista Novia del Mediodía Km 6½ e/Autopista Nacional y Carretera Central, La Habana, Cuba." } }, { "@type": "Person", "name": "Jorge Fraga Nodarse", "url": "https://questionsmedicales.fr/author/Jorge%20Fraga%20Nodarse", "affiliation": { "@type": "Organization", "name": "Departamento de Parasitología, Instituto \"Pedro Kourí\", Autopista Novia del Mediodía Km 6½ e/Autopista Nacional y Carretera Central, La Habana, Cuba." } }, { "@type": "Person", "name": "Raul Cordovi Prado", "url": "https://questionsmedicales.fr/author/Raul%20Cordovi%20Prado", "affiliation": { "@type": "Organization", "name": "Departamento de Parasitología, Instituto \"Pedro Kourí\", Autopista Novia del Mediodía Km 6½ e/Autopista Nacional y Carretera Central, La Habana, Cuba." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Operative treatment of cystic prolactinomas: a retrospective study.", "datePublished": "2023-05-04", "url": "https://questionsmedicales.fr/article/37143054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12902-023-01343-0" } }, { "@type": "ScholarlyArticle", "name": "Synchronous jawbone diseases: a multicenter retrospective study.", "datePublished": "2023-02-13", "url": "https://questionsmedicales.fr/article/36790252", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1807-3107bor-2023.vol37.0011" } }, { "@type": "ScholarlyArticle", "name": "A retrospective study of the malignant change of odontogenic keratocyst.", "datePublished": "2023-04-06", "url": "https://questionsmedicales.fr/article/37030439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jormas.2023.101466" } }, { "@type": "ScholarlyArticle", "name": "Epicardial and liver fat implications in albuminuria: a retrospective study.", "datePublished": "2024-08-22", "url": "https://questionsmedicales.fr/article/39175063", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12933-024-02399-5" } }, { "@type": "ScholarlyArticle", "name": "Pregnancy planning and neonatal outcome - a retrospective cohort study.", "datePublished": "2024-03-16", "url": "https://questionsmedicales.fr/article/38493168", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-024-06401-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Caractéristiques des études épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D016020" }, { "@type": "ListItem", "position": 6, "name": "Études épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D016021" }, { "@type": "ListItem", "position": 7, "name": "Études de cohortes", "item": "https://questionsmedicales.fr/mesh/D015331" }, { "@type": "ListItem", "position": 8, "name": "Études rétrospectives", "item": "https://questionsmedicales.fr/mesh/D012189" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Études rétrospectives - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Études rétrospectives", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Études rétrospectives", "description": "Comment les études rétrospectives aident-elles au diagnostic ?\nPeut-on établir un diagnostic précis avec ces études ?\nQuels outils sont utilisés dans ces études pour le diagnostic ?\nLes biais affectent-ils le diagnostic dans ces études ?\nLes études rétrospectives peuvent-elles confirmer un diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Études rétrospectives", "description": "Comment les symptômes sont-ils analysés dans ces études ?\nLes études rétrospectives identifient-elles de nouveaux symptômes ?\nPeut-on quantifier la gravité des symptômes ?\nLes symptômes sont-ils toujours fiables dans ces études ?\nLes études rétrospectives peuvent-elles aider à comprendre l'évolution des symptômes ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Études rétrospectives", "description": "Comment ces études contribuent-elles à la prévention ?\nPeut-on évaluer l'impact des programmes de prévention ?\nLes études rétrospectives peuvent-elles aider à cibler des populations à risque ?\nLes résultats de prévention sont-ils toujours fiables ?\nLes études rétrospectives peuvent-elles influencer les politiques de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Études rétrospectives", "description": "Comment les traitements sont-ils évalués dans ces études ?\nLes études rétrospectives peuvent-elles influencer les choix de traitement ?\nPeut-on comparer différents traitements avec ces études ?\nLes effets secondaires des traitements sont-ils étudiés ?\nLes études rétrospectives peuvent-elles révéler des traitements non efficaces ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Études rétrospectives", "description": "Comment les complications sont-elles identifiées dans ces études ?\nPeut-on établir un lien entre traitement et complications ?\nLes études rétrospectives peuvent-elles révéler des complications rares ?\nLes complications sont-elles toujours bien documentées ?\nLes études rétrospectives aident-elles à prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Études rétrospectives", "description": "Comment les facteurs de risque sont-ils identifiés ?\nLes études rétrospectives peuvent-elles révéler de nouveaux facteurs de risque ?\nPeut-on quantifier l'impact des facteurs de risque ?\nLes facteurs de risque sont-ils toujours fiables ?\nLes études rétrospectives aident-elles à cibler les interventions préventives ?", "url": "https://questionsmedicales.fr/mesh/D012189?page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les études rétrospectives aident-elles au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des tendances et des facteurs associés à des maladies." } }, { "@type": "Question", "name": "Peut-on établir un diagnostic précis avec ces études ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles fournissent des indices, mais ne remplacent pas les études prospectives pour un diagnostic définitif." } }, { "@type": "Question", "name": "Quels outils sont utilisés dans ces études pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des bases de données médicales et des dossiers patients sont souvent analysés." } }, { "@type": "Question", "name": "Les biais affectent-ils le diagnostic dans ces études ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biais de sélection et de rappel peuvent influencer les résultats diagnostiques." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles confirmer un diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent soutenir un diagnostic, mais nécessitent des études complémentaires pour confirmation." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils analysés dans ces études ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes rapportés dans les dossiers sont examinés pour établir des corrélations." } }, { "@type": "Question", "name": "Les études rétrospectives identifient-elles de nouveaux symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent révéler des symptômes associés à des conditions, mais nécessitent validation." } }, { "@type": "Question", "name": "Peut-on quantifier la gravité des symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en utilisant des échelles de mesure dans les données collectées." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours fiables dans ces études ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, la fiabilité dépend de la précision des rapports des patients et des enregistrements." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles aider à comprendre l'évolution des symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'observer l'évolution des symptômes au fil du temps." } }, { "@type": "Question", "name": "Comment ces études contribuent-elles à la prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des facteurs de risque et des tendances pouvant guider les stratégies préventives." } }, { "@type": "Question", "name": "Peut-on évaluer l'impact des programmes de prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en analysant les données avant et après la mise en œuvre des programmes." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles aider à cibler des populations à risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent d'identifier des groupes spécifiques à risque accru." } }, { "@type": "Question", "name": "Les résultats de prévention sont-ils toujours fiables ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, la fiabilité dépend de la qualité des données et des biais potentiels." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles influencer les politiques de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des preuves qui peuvent orienter les décisions politiques." } }, { "@type": "Question", "name": "Comment les traitements sont-ils évalués dans ces études ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les résultats des traitements passés sont analysés pour déterminer leur efficacité." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles influencer les choix de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent fournir des données sur l'efficacité des traitements antérieurs." } }, { "@type": "Question", "name": "Peut-on comparer différents traitements avec ces études ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en analysant les résultats de patients ayant reçu des traitements différents." } }, { "@type": "Question", "name": "Les effets secondaires des traitements sont-ils étudiés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets indésirables rapportés dans les dossiers sont souvent analysés." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles révéler des traitements non efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent identifier des traitements avec des résultats médiocres, mais avec prudence." } }, { "@type": "Question", "name": "Comment les complications sont-elles identifiées dans ces études ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont souvent rapportées dans les dossiers médicaux et analysées pour des associations." } }, { "@type": "Question", "name": "Peut-on établir un lien entre traitement et complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en comparant les résultats des patients ayant subi différents traitements." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles révéler des complications rares ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent, mais la rareté nécessite souvent des études plus larges pour confirmation." } }, { "@type": "Question", "name": "Les complications sont-elles toujours bien documentées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Non, la documentation peut être incomplète, ce qui affecte l'analyse." } }, { "@type": "Question", "name": "Les études rétrospectives aident-elles à prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent identifier des facteurs de risque, mais ne garantissent pas la prévention." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils identifiés ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont analysés à partir des données historiques des patients et des résultats de santé." } }, { "@type": "Question", "name": "Les études rétrospectives peuvent-elles révéler de nouveaux facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent, mais nécessitent validation par des études prospectives." } }, { "@type": "Question", "name": "Peut-on quantifier l'impact des facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en utilisant des modèles statistiques pour évaluer leur association avec des maladies." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils toujours fiables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Non, la fiabilité dépend de la qualité des données et des biais potentiels." } }, { "@type": "Question", "name": "Les études rétrospectives aident-elles à cibler les interventions préventives ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles identifient des groupes à risque qui peuvent bénéficier d'interventions ciblées." } } ] } ] }

Sources (10000 au total)

Operative treatment of cystic prolactinomas: a retrospective study.

The optimal therapeutic approach for cystic prolactinomas remains unclear. This study aimed to evaluate the remission rates of prolactinoma patients after surgical treatment and the risk factors affec... The clinical data were retrospectively compiled from 141 patients with prolactinomas (including 41 cases of cystic prolactinomas, 21 cases of solid microprolactinomas and 79 cases of solid macroprolac... Early postoperative remission was achieved in 65.83% (n = 27/41) of cystic prolactinomas, 80.95% (n = 17/21) of solid microprolactinomas and 40.51% (n = 32/79) of solid macroprolactinomas. The mean le... For cystic prolactinomas, tumor size and preoperative PRL levels were independent predictors of early postoperative remission. Preoperative DA therapy combined with TSS may be more beneficial to cysti...

Epicardial and liver fat implications in albuminuria: a retrospective study.

Albuminuria is considered an early and sensitive marker of kidney dysfunction, but also an independent cardiovascular risk factor. Considering the possible relationship among metabolic liver disease, ... A retrospective long-term longitudinal study including 181 patients was carried out. Epicardial adipose tissue and steatotic liver disease were assessed by computed tomography. The presence of albumin... After a median follow up of 11.2 years, steatotic liver disease (HR 3.15; 95% CI, 1.20-8.26; p = 0.02) and excess amount of epicardial adipose tissue (HR 6.12; 95% CI, 1.69-22.19; p = 0.006) were asso... Identification and management/decrease of excess adiposity must be a target in the primary and secondary prevention of chronic kidney disease development and progression. Visceral adiposity assessment...

Pregnancy planning and neonatal outcome - a retrospective cohort study.

Unplanned pregnancy is common, and although some research indicates adverse outcomes for the neonate, such as death, low birth weight, and preterm birth, results are inconsistent. The purpose of the p... We conducted a retrospective cohort study in which data from 2953 women were retrieved from the Swedish Pregnancy Planning Study, covering ten Swedish counties from September 2012 through July 2013. P... The prevalence of unplanned pregnancies was 30.4%. Compared with women who had planned pregnancies, those with unplanned pregnancies were more likely to give birth to neonates small for gestational ag... In a Swedish setting, an unplanned pregnancy might increase the risk for birth of an infant small for gestational age....

Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study.

The incidence and clinical features of primary cutaneous lymphoma (PCL) tend to differ by age, gender, geographical, and racial variation. All-aged and adult groups of PCL in various regions have been... The aim of this study was to investigate the clinical characteristics of PCL in pediatric population at a single center in China.... We conducted a retrospective study of 101 pediatric cases with PCL, diagnosed at the Institute of Dermatology, Chinese Academy of Medical Sciences, from January 2010 to December 2021.... Mycosis fungoides (MF), accounting for 41.6% of the total cases, was the most common subtype in pediatric PCL, and the hypopigmented MF accounted for 47.6% of all the MF cases. Lymphomatoid papulosis ... The study suggested that MF was the most common subtype in pediatric PCL in China, and most types of pediatric PCL had favorable prognosis....

Multiple sclerosis and COVID-19: A retrospective study in Iran.

Previous studies suggested a higher rate of COVID-19 infection in patients with multiple sclerosis than in the general population, and limited studies addressed the impact of COVID-19 and its vaccinat... We used the data of the patients with multiple sclerosis registered in a referral clinic in Kerman, one of the large cities in Iran (a population of 537,000 inhabitants), to explore the association be... Of the 367 participants in this study, 88.3% received the COVID-19 vaccine, 35.4% were confirmed COVID-19 cases, and the incidence of COVID-19 was much higher before vaccination (24.5% before vaccinat... Our findings showed that the vaccination protected MS cases considerably against COVID-19. In addition, the side effects of the vaccines were not noticeably high in these cases as well. Among all COVI...

Ocular adnexal lymphoma - a retrospective study and review of the literature.

To review the characteristics of all Slovenian patients with ocular adnexal lymphoma (OAL) in the period of 24 years with the aim of evaluating demographic data, lymphoma location and type, disease st... All patients with histologically diagnosed OAL in the main tertiary centre of Slovenia, Eye Hospital, University Medical Centre Ljubljana, who were treated at Institute of Oncology Ljubljana were incl... Seventy-four patients were included in the study having a median age of 68 years at diagnosis. The majority of lymphomas were of B-cell origin (98.6%). The most frequent type was the extranodal margin... OALs comprise a group of heterogeneous diseases with variable outcomes depending predominately on the patient's age and lymphoma type, with low grade lymphomas carrying good prognosis even in elderly ...